Phase I Strategies Tailored for Success

White Paper - Early Phase Oncology Trial Designs
Phase I Strategies Tailored for SuccessLearn about advanced Phase I trial designs that help accelerate your pathway to approval.

With the FDA’s launch of Project Optimus, which emphasizes the need to determine the optimal safe and efficacious doses earlier, designing the right Phase I study protocol for your therapy has become more important for success.

Download this white paper to learn more about:

  • Strategies for more accurate dose escalation to find the maximum effective dose
  • Benefits and Limitations of Rule-base, Model-based, and Model-assisted study designs
  • Accelerating your pathway to approval by gathering more information earlier

Download White Paper

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content